Terminated NA INTERVENTIONAL 2-arm NCT01867918

LOTCOL Study: Local Treatment of Colo-rectal Liver Met (LOTCOL)

A Randomized Study With Palliative Chemotherapy With or Without Local Treatment of Liver Metastases in Patients With Colo-rectal Cancer

Sponsor: Oslo University Hospital

Conditions Metastatic Colo-rectal Cancer

Interventions Radiofrequency ablation, microwave, radiation therapy Standard Chemotherapy

Updated 6 times since 2017 Last updated: Jan 6, 2017 Started: May 31, 2013 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Insuffisient recruitment

Other terminated trials from Oslo University Hospital

See all terminations from Oslo University Hospital

A NA clinical study on Metastatic Colo-rectal Cancer, this trial is terminated or withdrawn. The trial is conducted by Oslo University Hospital and has accumulated 6 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Feb 2017 — Jun 2018 [monthly]

Terminated NA

Status: Recruiting → Terminated

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Recruiting NA

First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Oslo University Hospital

Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway